Sweeping tariffs send shockwaves through the pharma sector, as experts warn of consumer detriment and supply chain risks. Already registered? If you don't have a login or your access has expired, you ...

The General Court has handed a win to generic drug makers including Teva and Mylan in the battle over multiple sclerosis drug ...

The firm’s Technology & Engineering team will be expanded with an expert in patent drafting, prosecution and ...

Budget constraints and keeping up with advancing technology are the top challenges facing European life sciences patent ...

A biotech firm specialising in mRNA therapies alleges AbbVie’s $2.1 billion Capstan purchase was built on stolen lipid ...

24 June 2025 Coke Morgan Stewart has issued a raft of decisions under new guidance intended to improve the US patent appeals ...

There are varying national eligibility requirements that distinguish between treatments of and diagnostics for animals and ...

US firm’s new partner “brings a rare combination of scientific depth, global perspective, and strategic legal insight” to her ...

Front row L to R: Steven Pepe, David Chun, Jim Davis; back row L to R: Matthew Shapiro and Kevin Post The exodus of patent ...

16 September 2025 From drug discovery to post-market surveillance, AI is rewriting the rules in pharma—and the patent system ...